Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
SAP (XTRA:SAP) is discontinuing its IS-H healthcare solution, affecting more than 60 hospitals and clinics in the DACH region.
The company is transferring its strategic hospital template to Snap Consulting as part of the change in its healthcare offering.
David Robinson has been appointed President of SAP North America, marking a change in regional leadership.
For you as an investor or customer, these moves sit at the intersection of SAP’s core enterprise resource planning business and sector specific offerings, especially in healthcare IT. Hospitals that relied on IS-H in the DACH region now face product transition decisions. At the same time, the handover of the template to Snap Consulting points to a different role for SAP in industry solutions.
On the leadership side, David Robinson’s appointment in North America could influence how SAP prioritises products, sales execution, and customer focus in one of its key regions. Together, the healthcare shift and the leadership change give you new information to track how SAP (XTRA:SAP) is positioning its portfolio and regional operations.
Stay updated on the most important news stories for SAP by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on SAP.
XTRA:SAP Earnings & Revenue Growth as at Jan 2026
How SAP stacks up against its biggest competitors
✅ Price vs Analyst Target: At €164.62 against a consensus target of €271.86, the price sits about 39% below analyst expectations.
✅ Simply Wall St Valuation: Shares are flagged as trading 52.8% below the platform’s estimated fair value.
❌ Recent Momentum: The 30 day return is about a 21% decline, which signals weak short term momentum.
Check out Simply Wall St’s in depth valuation analysis for SAP.
📊 The phase out of IS-H and handover to Snap Consulting suggests SAP is refining its healthcare focus, while a new North America president could influence regional priorities.
📊 Watch how healthcare related revenue, customer retention in the DACH region, and execution in North America track against the current €164.62 price and analyst target of €271.86.
⚠️ The main risk to watch is potential disruption for hospital customers during the IS-H transition, which could affect sentiment toward SAP’s sector specific solutions.
For the full picture, including more risks and rewards, check out the complete SAP analysis.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.